Cardiac magnetic resonance shows increased adverse ventricular remodeling in younger patients after ST-segment

Ruifeng Guo1, Xiao Wang2, Qian Guo1

  • 1Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.

European Radiology
|January 26, 2023
PubMed

Insights

Young patients with ST-segment elevation myocardial infarction (STEMI) experience worse ventricular remodeling after primary percutaneous coronary intervention (PPCI). These younger individuals face a higher risk of adverse remodeling and are less likely to achieve reverse remodeling compared to older patients.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Clinical Research

Background:

  • Young patients constitute approximately 50% of ST-segment elevation myocardial infarction (STEMI) cases.
  • STEMI patients under 60 exhibit a distinct risk profile compared to older individuals.
  • The role of ventricular remodeling in age-related disparities post-STEMI remains unclear.

Purpose of the Study:

  • To investigate age-related differences in ventricular remodeling following primary percutaneous coronary intervention (PPCI) in STEMI patients.
  • To compare adverse and reverse remodeling patterns between young (<60 years) and old (≥60 years) STEMI patients.
  • To identify if younger age is a predictor of unfavorable ventricular remodeling post-STEMI.

Main Methods:

  • An observational study involving 123 STEMI patients who underwent PPCI.
  • Serial cardiovascular magnetic resonance imaging was performed at baseline (3-7 days) and 3 months post-PPCI.
  • Adverse remodeling was defined as ≥10% increase in left ventricular end-diastolic volume index (LVEDVi); reverse remodeling as >10% decrease in left ventricular end-systolic volume index (LVESVi).

Main Results:

  • Younger patients (n=71) showed a significantly higher incidence of adverse remodeling (49.3% vs 30.8%, p=0.039) and lower reverse remodeling (31.0% vs 53.8%, p=0.011) compared to older patients (n=52).
  • Left ventricular end-systolic volume index (LVESVi) significantly decreased only in the older patient group.
  • Younger age (<60 years) was independently associated with increased risk of adverse remodeling (aOR 3.51) and decreased likelihood of reverse remodeling (aOR 0.42).

Conclusions:

  • Young STEMI patients undergoing PPCI exhibit unfavorable ventricular remodeling compared to older counterparts.
  • Younger individuals are at higher risk for adverse remodeling and less likely to achieve reverse remodeling post-STEMI.
  • Increased clinical attention and tailored management strategies are warranted for young STEMI patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
25
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
20
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29